VBS Board of Directors
David M. Mann, Chairman, Vascular BioSciences & VBS Pharmaceuticals
As the founder of both Vascular BioSciences and VBS Pharmaceuticals, Mr. Mann has led Vascular BioSciences since its inception in 1995, and VBS Pharmaceuticals since 2004. Mr. Mann is the inventor of the endoarterial biopsy catheter and co-discoverer of CAR peptide’s utility for pulmonary hypertension, sepsis and other diseases. Mr. Mann has been awarded over 30 patents both U.S. and foreign, is an author of 18 scientific publications, and has been awarded 10 highly competitive federal and state research grants totaling $5.8 million as the Principal or Co-Principal Investigator. David Mann holds an engineering physics degree from the University of Colorado, Boulder.
Masanobu Komatsu, Ph.D., Board Member, VBS Pharmaceuticals
Associate professor and cancer researcher at Sanford-Burnham Medical Research Institute at Lake Noma with a focus on the biology of angiogenesis, with particular interest in the vessel maturation process. Dr. Komatsu seeks to understand the process of abnormal blood vessel remodeling and regeneration, and through this knowledge, to develop effective interventions for vascular disorders and vascular complications. His other area of research is to develop novel vascular targeting strategies for the delivery of therapeutics and imaging probes in various human diseases. For more information about Dr. Masanobu Komatsu, http://www.sanfordburnham.org/talent/Pages/MasanobuKomatsu.aspx
Kalju Kahn, Ph.D., Board Member, Vascular BioSciences &
VBS Pharmaceuticals
Dr. Kalju Kahn has over 20 years experience in computational chemistry and drug design. Dr. Kahn has published more than 20 journal articles and has been awarded three grants for computational design and infrastructure, one from the Christopher Reeve Paralysis Foundation for computational design of putative neuroregenerative drugs. At the University of California, Santa Barbara, he is a tenured lecturer in the biochemistry and chemistry departments. He focuses on theoretical chemistry methods to predict molecular properties and experimental design and optimization. For more information about Dr. Kalju Kahn, please visit: http://www.chem.ucsb.edu/people/kalju-kahn
Roy Williams, Ph.D., Board Member, Vascular BioSciences
Currently a bioinformatics specialist at The Scripps Research Institute, Dr. Roy Williams works on data analysis (microarray and proteomics) and genome annotation. With 15 years of experience, Dr. Roy Williams is an internationally recognized pioneer in genomics, microarray technology, and the computer-based analysis of complex genome-wide datasets. He has a focus on large-scale analysis of microarray datasets and next generation sequence data analysis.
